The E3 ligase Thin controls homeostatic plasticity through neurotransmitter release repression.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35796533.
- Also identified by DOI 10.7554/eLife.71437 and PMC identifier 9299833.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Synaptic proteins and synaptic transmission are under homeostatic control, but the relationship between these two processes remains enigmatic. Here, we systematically investigated the role of E3 ubiquitin ligases, key regulators of protein degradation-mediated proteostasis, in presynaptic homeostatic plasticity (PHP). An electrophysiology-based genetic screen of 157 E3 ligase-encoding genes at the <i>Drosophila</i> neuromuscular junction identified <i>thin</i>, an ortholog of human <i>tripartite motif-containing 32</i> (<i>TRIM32</i>), a gene implicated in several neurological disorders, including autism spectrum disorder and schizophrenia. We demonstrate that <i>thin</i> functions presynaptically during rapid and sustained PHP. Presynaptic <i>thin</i> negatively regulates neurotransmitter release under baseline conditions by limiting the number of release-ready vesicles, largely independent of gross morphological defects. We provide genetic evidence that <i>thin</i> controls release through <i>dysbindin</i>, a schizophrenia-susceptibility gene required for PHP. Thin and Dysbindin localize in proximity within presynaptic boutons, and Thin degrades Dysbindin in vitro. Thus, the E3 ligase Thin links protein degradation-dependent proteostasis of Dysbindin to homeostatic regulation of neurotransmitter release.
Medical subject headings
- Autism Spectrum Disorder
- Drosophila Proteins